<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<GBSeq>

    <GBSeq_locus>NM_001346937</GBSeq_locus>
    <GBSeq_length>629</GBSeq_length>
    <GBSeq_strandedness>single</GBSeq_strandedness>
    <GBSeq_moltype>mRNA</GBSeq_moltype>
    <GBSeq_topology>linear</GBSeq_topology>
    <GBSeq_division>PRI</GBSeq_division>
    <GBSeq_update-date>23-APR-2019</GBSeq_update-date>
    <GBSeq_create-date>08-NOV-2016</GBSeq_create-date>
    <GBSeq_definition>Homo sapiens interferon lambda 3 (IFNL3), transcript variant 1, mRNA</GBSeq_definition>
    <GBSeq_primary-accession>NM_001346937</GBSeq_primary-accession>
    <GBSeq_accession-version>NM_001346937.1</GBSeq_accession-version>
    <GBSeq_other-seqids>
      <GBSeqid>ref|NM_001346937.1|</GBSeqid>
      <GBSeqid>gi|1100961535</GBSeqid>
    </GBSeq_other-seqids>
    <GBSeq_secondary-accessions>
      <GBSecondary-accn>XM_005258765</GBSecondary-accn>
    </GBSeq_secondary-accessions>
    <GBSeq_keywords>
      <GBKeyword>RefSeq</GBKeyword>
    </GBSeq_keywords>
    <GBSeq_source>Homo sapiens (human)</GBSeq_source>
    <GBSeq_organism>Homo sapiens</GBSeq_organism>
    <GBSeq_taxonomy>Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo</GBSeq_taxonomy>
    <GBSeq_references>
      <GBReference>
        <GBReference_reference>1</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Aytekin FY</GBAuthor>
          <GBAuthor>Barut HS</GBAuthor>
          <GBAuthor>Rustemoglu A</GBAuthor>
          <GBAuthor>Atay A</GBAuthor>
          <GBAuthor>Gunal O</GBAuthor>
          <GBAuthor>Duygu F</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Factors related to fatalities and clinical progression of Crimean-Congo hemorrhagic fever patients and the effects of IL 28-B gene polymorphism</GBReference_title>
        <GBReference_journal>Arch. Virol. 164 (2), 547-557 (2019)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1007/s00705-018-4106-1</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>30478788</GBReference_pubmed>
        <GBReference_remark>GeneRIF: The IL 28-B rs12979860 polymorphism was not found to have a statistically significant correlation with fatality or symptoms indicating serious clinical progression in Crimean-Congo hemorrhagic fever patients.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>2</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Ali Q</GBAuthor>
          <GBAuthor>Jamal A</GBAuthor>
          <GBAuthor>Imran M</GBAuthor>
          <GBAuthor>Ullah S</GBAuthor>
          <GBAuthor>Kalam I</GBAuthor>
          <GBAuthor>Ullah S</GBAuthor>
          <GBAuthor>Waqar AB</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Correlation of IL28B rs12979860 genotype and gender with spontaneous clearance of HCV infection: a Pakistani cross-section study</GBReference_title>
        <GBReference_journal>Per Med 15 (6), 495-502 (2018)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.2217/pme-2018-0016</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>30398404</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Our results showed that IL28B rs12979860 CT was critically involved in spontaneous clearance of HCV infection and there is an independent role of the favorable IL28B rs12979860 CT genotype and female gender with spontaneous clearance of Hepatitis C Virus infection in the Pakistani population.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>3</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Chen JY</GBAuthor>
          <GBAuthor>Wang CM</GBAuthor>
          <GBAuthor>Chen TD</GBAuthor>
          <GBAuthor>Jan Wu YJ</GBAuthor>
          <GBAuthor>Lin JC</GBAuthor>
          <GBAuthor>Lu LY</GBAuthor>
          <GBAuthor>Wu J</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Interferon-lambda3/4 genetic variants and interferon-lambda3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese</GBReference_title>
        <GBReference_journal>Arthritis Res. Ther. 20 (1), 193 (2018)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1186/s13075-018-1683-z</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>30157968</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Interferon lambda 3 (IFN-lambda3)/interferon lambda 4 (IFNlambda4) genetic variants play a unique role in the development of lupus nephritis and systemic lupus erythematosus (SLE).; Publication Status: Online-Only</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>4</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Semenov,S.I.</GBAuthor>
          <GBAuthor>Fedorov,A.L.</GBAuthor>
          <GBAuthor>Osakovsky,V.L.</GBAuthor>
          <GBAuthor>Maksimova,S.S.</GBAuthor>
          <GBAuthor>Platonov,F.A.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>[FREQUENCY OF OCCURRENCE OF POLYMORPHIC VARIANTS OF IL28B GENE AND GENOTYPES OF HEPATITIS C VIRUS IN POPULATION OF YAKUTIA: CLINICAL OUTCOMES]</GBReference_title>
        <GBReference_journal>Zh. Mikrobiol. Epidemiol. Immunobiol. (2), 86-92 (2017)</GBReference_journal>
        <GBReference_pubmed>30695542</GBReference_pubmed>
        <GBReference_remark>GeneRIF: Combination of HCV lb with polymorphic variants of IL28B'gene rs12979860 CC and rs8099917 CT showed a less aggressive course of the disease. On the other hand, HCV infection of individuals with geno- type 3a and polymorphism rs12979860 CC or rs809917 TT of IL28B gene showed a more severe clinical presentation.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>5</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Matinyan,I.A.</GBAuthor>
          <GBAuthor>Sentsova,T.B.</GBAuthor>
          <GBAuthor>Vorozhko,I.V.</GBAuthor>
          <GBAuthor>Chernyak,O.O.</GBAuthor>
          <GBAuthor>Strokova,T.V.</GBAuthor>
          <GBAuthor>Gapparov,M.M.G.</GBAuthor>
        </GBReference_authors>
        <GBReference_title>[THE CLINICAL COURSE OF HEPATITIS C IN CHILDREN WITH DIFFERENT VARIANTS OF THE GENE POLYMORPHISM IL28B]</GBReference_title>
        <GBReference_journal>Eksp Klin Gastroenterol (7), 52-55 (2016)</GBReference_journal>
        <GBReference_pubmed>30284423</GBReference_pubmed>
        <GBReference_remark>GeneRIF: When analyzing the frequency of occurrence of a polymorphic variant T&gt;G [rs8099917] IL-28B gene in children with chronic hepatitis C and healthy children revealed no differences in the distribution of alleles.</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>6</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Mennechet FJ</GBAuthor>
          <GBAuthor>Uze G</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells</GBReference_title>
        <GBReference_journal>Blood 107 (11), 4417-4423 (2006)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1182/blood-2005-10-4129</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>16478884</GBReference_pubmed>
        <GBReference_remark>GeneRIF: IFN-lambdas are thus able to generate tolerogenic DCs, an activity that could thwart IFN-beta functions</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>7</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Li M</GBAuthor>
          <GBAuthor>He S</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Purification and characterization of recombinant human interleukin-29 expressed in Escherichia coli</GBReference_title>
        <GBReference_journal>J. Biotechnol. 122 (3), 334-340 (2006)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1016/j.jbiotec.2005.11.019</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>16413080</GBReference_pubmed>
      </GBReference>
      <GBReference>
        <GBReference_reference>8</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Li MC</GBAuthor>
          <GBAuthor>Wang HY</GBAuthor>
          <GBAuthor>Wang HY</GBAuthor>
          <GBAuthor>Li T</GBAuthor>
          <GBAuthor>He SH</GBAuthor>
        </GBReference_authors>
        <GBReference_title>Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells</GBReference_title>
        <GBReference_journal>Acta Pharmacol. Sin. 27 (4), 453-459 (2006)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1111/j.1745-7254.2006.00292.x</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>16539846</GBReference_pubmed>
      </GBReference>
      <GBReference>
        <GBReference_reference>9</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Kotenko SV</GBAuthor>
          <GBAuthor>Gallagher G</GBAuthor>
          <GBAuthor>Baurin VV</GBAuthor>
          <GBAuthor>Lewis-Antes A</GBAuthor>
          <GBAuthor>Shen M</GBAuthor>
          <GBAuthor>Shah NK</GBAuthor>
          <GBAuthor>Langer JA</GBAuthor>
          <GBAuthor>Sheikh F</GBAuthor>
          <GBAuthor>Dickensheets H</GBAuthor>
          <GBAuthor>Donnelly RP</GBAuthor>
        </GBReference_authors>
        <GBReference_title>IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex</GBReference_title>
        <GBReference_journal>Nat. Immunol. 4 (1), 69-77 (2003)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1038/ni875</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>12483210</GBReference_pubmed>
        <GBReference_remark>GeneRIF: closely positioned genes on human chromosome 19 encode distinct but paralogous proteins, which we designate interferon-lambda1 (IFN-lambda1), IFN-lambda2 and IFN-lambda3</GBReference_remark>
      </GBReference>
      <GBReference>
        <GBReference_reference>10</GBReference_reference>
        <GBReference_position>1..629</GBReference_position>
        <GBReference_authors>
          <GBAuthor>Sheppard P</GBAuthor>
          <GBAuthor>Kindsvogel W</GBAuthor>
          <GBAuthor>Xu W</GBAuthor>
          <GBAuthor>Henderson K</GBAuthor>
          <GBAuthor>Schlutsmeyer S</GBAuthor>
          <GBAuthor>Whitmore TE</GBAuthor>
          <GBAuthor>Kuestner R</GBAuthor>
          <GBAuthor>Garrigues U</GBAuthor>
          <GBAuthor>Birks C</GBAuthor>
          <GBAuthor>Roraback J</GBAuthor>
          <GBAuthor>Ostrander C</GBAuthor>
          <GBAuthor>Dong D</GBAuthor>
          <GBAuthor>Shin J</GBAuthor>
          <GBAuthor>Presnell S</GBAuthor>
          <GBAuthor>Fox B</GBAuthor>
          <GBAuthor>Haldeman B</GBAuthor>
          <GBAuthor>Cooper E</GBAuthor>
          <GBAuthor>Taft D</GBAuthor>
          <GBAuthor>Gilbert T</GBAuthor>
          <GBAuthor>Grant FJ</GBAuthor>
          <GBAuthor>Tackett M</GBAuthor>
          <GBAuthor>Krivan W</GBAuthor>
          <GBAuthor>McKnight G</GBAuthor>
          <GBAuthor>Clegg C</GBAuthor>
          <GBAuthor>Foster D</GBAuthor>
          <GBAuthor>Klucher KM</GBAuthor>
        </GBReference_authors>
        <GBReference_title>IL-28, IL-29 and their class II cytokine receptor IL-28R</GBReference_title>
        <GBReference_journal>Nat. Immunol. 4 (1), 63-68 (2003)</GBReference_journal>
        <GBReference_xref>
          <GBXref>
            <GBXref_dbname>doi</GBXref_dbname>
            <GBXref_id>10.1038/ni873</GBXref_id>
          </GBXref>
        </GBReference_xref>
        <GBReference_pubmed>12469119</GBReference_pubmed>
        <GBReference_remark>GeneRIF: identified from the human genomic sequence a family of three cytokines, designated interleukin 28A (IL-28A), IL-28B and IL-29, that are distantly related to type I interferons (IFNs) and the IL-10 family</GBReference_remark>
      </GBReference>
    </GBSeq_references>
    <GBSeq_comment>REVIEWED REFSEQ: This record has been curated by NCBI staff. The reference sequence was derived from AY129149.1 and BC130316.1.; On Nov 8, 2016 this sequence version replaced XM_005258765.4.; ~Summary: This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28A (IL28A), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). [provided by RefSeq, Jul 2008].; ~Transcript Variant: This variant (1) encodes the longer isoform (1). This isoform does not contain a signal peptide, compared to isoform 2.; ~Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications.; ; ##Evidence-Data-START## ; Transcript exon combination :: AY129149.1 [ECO:0000332] ; RNAseq introns :: mixed/partial sample support SAMEA1968968, SAMEA2148093 [ECO:0000350] ; ##Evidence-Data-END##</GBSeq_comment>
    <GBSeq_primary>REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP~1-603               AY129149.1         1-603~604-629             BC130316.1         631-656</GBSeq_primary>
    <GBSeq_feature-table>
      <GBFeature>
        <GBFeature_key>source</GBFeature_key>
        <GBFeature_location>1..629</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>629</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>organism</GBQualifier_name>
            <GBQualifier_value>Homo sapiens</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>mol_type</GBQualifier_name>
            <GBQualifier_value>mRNA</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>taxon:9606</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>chromosome</GBQualifier_name>
            <GBQualifier_value>19</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>map</GBQualifier_name>
            <GBQualifier_value>19q13.2</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>gene</GBFeature_key>
        <GBFeature_location>1..629</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>629</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>interferon lambda 3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>GeneID:282617</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>HGNC:HGNC:18365</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>MIM:607402</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>CDS</GBFeature_key>
        <GBFeature_location>1..603</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>603</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>note</GBQualifier_name>
            <GBQualifier_value>isoform 1 is encoded by transcript variant 1; interleukin-28B; interferon, lambda 4; interleukin-28C; cytokine Zcyto22</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>codon_start</GBQualifier_name>
            <GBQualifier_value>1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>transl_table</GBQualifier_name>
            <GBQualifier_value>1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>product</GBQualifier_name>
            <GBQualifier_value>interferon lambda-3 isoform 1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>protein_id</GBQualifier_name>
            <GBQualifier_value>NP_001333866.1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>CCDS:CCDS86765.1</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>GeneID:282617</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>HGNC:HGNC:18365</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>db_xref</GBQualifier_name>
            <GBQualifier_value>MIM:607402</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>translation</GBQualifier_name>
            <GBQualifier_value>MKLDMTGDCMPVLVLMAAVLTVTGAVPVARLRGALPDARGCHIAQFKSLSPQELQAFKRAKDALEESLLLKDCKCRSRLFPRTWDLRQLQVRERPVALEAELALTLKVLEATADTDPALGDVLDQPLHTLHHILSQLRACIQPQPTAGPRTRGRLHHWLHRLQEAPKKESPGCLEASVTFNLFRLLTRDLNCVASGDLCV</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>1..10</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>1</GBInterval_from>
            <GBInterval_to>10</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>11..192</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>11</GBInterval_from>
            <GBInterval_to>192</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>193..270</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>193</GBInterval_from>
            <GBInterval_to>270</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>271..420</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>271</GBInterval_from>
            <GBInterval_to>420</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>421..504</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>421</GBInterval_from>
            <GBInterval_to>504</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
      <GBFeature>
        <GBFeature_key>exon</GBFeature_key>
        <GBFeature_location>505..629</GBFeature_location>
        <GBFeature_intervals>
          <GBInterval>
            <GBInterval_from>505</GBInterval_from>
            <GBInterval_to>629</GBInterval_to>
            <GBInterval_accession>NM_001346937.1</GBInterval_accession>
          </GBInterval>
        </GBFeature_intervals>
        <GBFeature_quals>
          <GBQualifier>
            <GBQualifier_name>gene</GBQualifier_name>
            <GBQualifier_value>IFNL3</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>gene_synonym</GBQualifier_name>
            <GBQualifier_value>IFN-lambda-3; IFN-lambda-4; IL-28B; IL-28C; IL28B; IL28C</GBQualifier_value>
          </GBQualifier>
          <GBQualifier>
            <GBQualifier_name>inference</GBQualifier_name>
            <GBQualifier_value>alignment:Splign:2.1.0</GBQualifier_value>
          </GBQualifier>
        </GBFeature_quals>
      </GBFeature>
    </GBSeq_feature-table>
    <GBSeq_sequence>atgaaactagacatgaccggggactgcatgccagtgctggtgctgatggccgcagtgctgaccgtgactggagcagttcctgtcgccaggctccgcggggctctcccggatgcaaggggctgccacatagcccagttcaagtccctgtctccacaggagctgcaggcctttaagagggccaaagatgccttagaagagtcgcttctgctgaaggactgcaagtgccgctcccgcctcttccccaggacctgggacctgaggcagctgcaggtgagggagcgccccgtggctttggaggctgagctggccctgacgctgaaggttctggaggccaccgctgacactgacccagccctgggggatgtcttggaccagccccttcacaccctgcaccatatcctctcccagctccgggcctgtatccagcctcagcccacggcagggcccaggacccggggccgcctccaccattggctgcaccggctccaggaggccccaaaaaaggagtcccctggctgcctcgaggcctctgtcaccttcaacctcttccgcctcctcacgcgagacctgaattgtgttgccagcggggacctgtgtgtctgacccttccgccagtcatgcaacctgag</GBSeq_sequence>
  </GBSeq>
